Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
CytoDyn Inc CYDY
(Total Views: 779)
Posted On: 08/14/2020 8:16:06 PM
Post# of 154089
Posted By: dfwl28
Somebody please reply directly to this guy with links that address his criticism. You can reply directly to his comment.

NY Times article:
https://www.nytimes.com/2020/08/14/health/cov...sContainer

Here is his negative comment.

" mockingjay
Boston
8m ago

Wow, out of 60 comments four of them are touting leronlimab and asking rhetorical questions: "The world has been waiting for a safe and effective treatment. It's Leromlimab!". None identify what the results are. Google searches show only that a study was released which seems to have failed its primary endpoint (for patient reported outcome) and did have a statistically significant impact (but not stated whether magnitude was clinically relevant) on improving a predictor-of-future-sickness score (but not stated if there were actual clinical outcomes, ie actually less future sickness).

I may not have all the data, but so far I am left with the suspicion that these are paid stock-pumpers, or true believers who are not very skeptical of prelim, unreviewed trial reports.

Regardless, I am sure that I will be flamed by either. Still, a plea: if you are for real, put data in your posts, not just assertions?"













(1)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site